The 30-60-90 Day Letter Protocol: How Continual Written Outreach Improves Mammography Follow-Up

The mandatory letter is only the starting point

The Mammography Quality Standards Act requires every facility to deliver a written summary of results to the patient in language a lay person can understand within thirty days of the examination. That letter is mandatory. A telephone call does not replace it. Yet many patients still do not act on it. Studies that examined written communication alone show that roughly one in four to one in three patients do not return for recommended diagnostic imaging within sixty days. In one clear comparison, only 73.1 percent of women with an incomplete assessment under the FDA-MQSA imaging assessment system (BI-RADS®) returned within sixty days when the facility relied on the written letter. Nearly 27 percent did not. Larger database analyses of incomplete assessments document follow-up rates as low as 66 percent. The letter states the clinical fact. It does not by itself remove fear, confusion, scheduling friction, or competing demands.^1,2

The power of continual written outreach: the 30-60-90 day letter protocol

A structured sequence of letters changes the equation. The first letter satisfies the regulatory requirement and establishes the recommendation. A second letter at approximately thirty days, a third at sixty days, and a final letter at ninety days keep the recommendation in front of the patient. Each successive letter can be more specific. Technology enables that specificity. Tracking systems identify non-responders, apply prior response history, language preference, and known barriers, and generate letters that speak more directly to the individual situation. This is hyper-personalization delivered through the mail: the system prepares content so each letter is no longer generic.

In our experience with the Mammologix 30-60-90 day follow-up letter protocol program, this continual written outreach, even without live human interaction, produces substantial improvement in follow-up compliance. Independent published studies have not yet quantified the exact operational magnitude of this specific protocol, yet the pattern of sequential written contact consistently improves return rates over a single letter. The mechanism is simple and repeatable. Patients who ignore the first notice receive a second and third clear call to action. The final letter also notifies the referring healthcare provider, closing the loop and prompting additional clinical reinforcement. Continual reaching out itself carries force. The repeated presence of a clear, actionable recommendation overcomes inertia that a single letter cannot.

Published evidence supports the broader principle that sequential or enhanced written outreach improves return rates. Facilities that improved the readability and actionability of the initial recall letter raised sixty-day follow-up from 90.1 percent to 93.9 percent. Studies of certified or registered letters sent after missed appointments show that a meaningful share of previously non-compliant patients return after the additional formal written notice. Sequential reminder systems that continue contact beyond the first letter consistently outperform single-touch approaches.^3,4

Adding the human factor multiplies the effect

The letter sequence creates a strong foundation. Layering personalized human contact on top of that foundation produces still greater impact. When facilities add next-business-day or interval telephone calls to the written sequence, adherence rises further and time to diagnostic imaging shortens. In the study that began with written communication only at 73.1 percent sixty-day return, the addition of telephone contact raised adherence to 87.6 percent and then 90.0 percent while cutting median time from twenty-eight days to nine days. Multi-level trials that combined a letter with a personal phone call improved completion of overdue follow-up from approximately 23 percent under usual care to 31 percent. Meta-analyses of patient navigation, which centers on structured human interaction, demonstrate consistent gains in follow-up after abnormal breast imaging results.^1,5,6

Technology again enables the scale. Tracking platforms surface the non-responder list with context so that a short, barrier-specific call can be made efficiently rather than as an unguided conversation. The human caller addresses the specific obstacle the letters have already flagged. The combination of continual written contact plus targeted human contact converts more patients than either channel alone.

Patient and operational consequences

Earlier return after an incomplete assessment under the FDA-MQSA imaging assessment system (BI-RADS®) shortens the interval to diagnostic resolution. It reduces the period of uncertainty for the patient and lowers the chance that a detectable lesion progresses. Operationally, higher compliance rates reduce lost-to-follow-up findings that later appear in audits and quality reviews. The final letter to the referring healthcare provider further strengthens the safety net by activating the clinical relationship the patient already trusts.

The leadership question

Communication leaders now face a practical systems choice. Does the facility stop at the single mandatory letter, or does it implement a reliable 30-60-90 day written sequence that keeps the recommendation in front of the patient and notifies the referring provider? Does the tracking platform generate those letters with enough personalization that each successive contact is more specific than the last? And once the written sequence is running, does the organization add the human layer for the remaining non-responders? Continual written outreach alone moves the needle. Technology makes that outreach precise. Adding personalized human interaction moves it further. The remaining variable is whether leadership treats sequenced communication as a core process rather than residual work after the first letter is mailed.

---

About the Author

Richard D. Lippert Jr. is the founder of Mammologix and has supported breast imaging centers with patient follow-up tracking, lay communication, compliance documentation, and operational strategy since 1995.

References

1. Nguyen DL, Oluyemi E, Myers KS, Harvey SC, Mullen LA, Ambinder EB. Impact of telephone communication on patient adherence with follow-up recommendations after an abnormal screening mammogram. J Am Coll Radiol. 2020;17(9):1139-1148. doi:10.1016/j.jacr.2020.03.030. Abstract (paywall)

2. Rate and Timeliness of Diagnostic Evaluation and Biopsy After Recall From Screening Mammography in the National Mammography Database. J Am Coll Radiol. 2024. Analysis of more than 2.8 million incomplete assessments documenting 66.4 percent follow-up. Abstract (paywall)

3. Impact of Improved Screening Mammography Recall Lay Letter Readability on Patient Follow-Up. J Am Coll Radiol. 2020. Sixty-day adherence rose from 90.1 percent to 93.9 percent after letter revision. Full text (PMC)

4. Impact of Certified Letters on Facilitating Breast Center Follow-Up Among High-risk Patients. J Am Coll Surg. 2021. Certified letter after missed appointment produced return in 70 percent of previously non-compliant high-risk patients. Abstract

5. Atlas SJ, Tosteson ANA, et al. A multilevel primary care intervention to improve follow-up of overdue abnormal cancer screening test results: a cluster randomized clinical trial. JAMA. 2023;330(14):1348-1358. doi:10.1001/jama.2023.18755. Full text

6. Patient navigation services for breast and cervical cancer screening and follow-up: a meta-analysis. JAMA Intern Med. 2025. Risk ratio 1.23 for follow-up after abnormal breast screening. Abstract (paywall)